At the news
? BEARISHIMPACT 6/10 S-3 filed Nov 9, 2026 at 08:00 ET
Turn Therapeutics filed an S-3 shelf registration to register the resale of 25,362,950 shares by selling stockholders, including up to 6,621,190 shares from GEM under an existing $85M committed equity facility. The company will not receive proceeds from the resale but may draw up to $85M from GEM for working capital. The registered shares represent 82.96% of outstanding shares, creating significant potential overhang. The filing coincides with a Q3 2026 net loss of $6.2M and $10.4M cash on hand, indicating a capital need.
- S-3 registers resale of 25,362,950 shares, representing 82.96% of 30,572,704 shares outstanding as of Nov 6, 2026
- Includes up to 6,621,190 shares from GEM under an $85M committed equity facility (GEM Purchase Agreement)
- Company may receive up to $85M from future draw downs to GEM; $75M remains available after $4.07M initial draw and $2.72M second draw
- GEM purchases shares at 90% of average daily closing price over 15-day pricing period, floor of $1.00 per share
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access